A practical guide to the analysis of sirolimus using high-performance liquid chromatography with ultraviolet detection

Clinical Therapeutics

Volumn 22, Issue SUPPL. B, 2000, Pages

  Napoli, Kimberly L ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

High performance liquid chromatography; Immunosuppressive; Sirolimus; Therapeutic drug monitoring; Transplantation

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; RAPAMYCIN;

ARTICLE; BLOOD SAMPLING; DRUG BLOOD LEVEL; DRUG MONITORING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTERMETHOD COMPARISON; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MASS SPECTROMETRY;

EID: 0034065399     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(00)89019-0     Document Type: Article

References (17)

1. Yatscoff R, LeGatt DF, Keenan R, Chackowsky P. Blood distribution of rapamycin. Transplantation. 1993;56:1202-1206.
2. Napoli KL, Kahan BD. High-performance liquid chromatography of rapamycin. Clin Chem. 1991;37:294-295.
3. Omura S, Tanaka H. Production, structure, and antifungal activity of polyene macrolides. In: Omura S, ed. Macrolide Antibiotics: Chemistry, Biology and Practice. New York: Academic Press; 1984: 351-396.
4. Napoli KL, Kahan BD. Sample clean-up and high-performance liquid chromatographic techniques for measurement of whole blood rapamycin concentrations. J Chromatogr B Biomed Appl. 1994;654: 111-120.
5. Napoli KL, Kahan BD. Routine clinical monitoring of sirolimus (rapamycin) whole-blood concentrations by HPLC with ultraviolet detection. Clin Chem. 1996;42:1943-1948.
6. Shah VP, Midha KK, Dighe S, et al. Analytical methods validation: Bioavailability, bioequivalence, and pharmacokinetic studies. J Pharm Sci. 1992;81:309-312.
7. Kahan BD, Podbielski J, Napoli KL, et al. Immunosuppressive effects and safety of a sirolimus/cyclosporine combination regimen for renal transplantation. Transplantation. 1998;66:1040-1046.
8. Kaplan B, Meier-Kriesehe H-U, Napoli KL, Kahan BD. The effects of relative timing of sirolimus and cyclosporine microemulsion formulation coadministration on the pharmacokinetics of each agent. Clin Pharmacol Ther. 1998;63:48-53.
9. Kaplan B, Meier-Kriesche H-U, Napoli KL, Kahan BD. Correlation between pretransplantation test dose cyclosporine pharmacokinetic profiles and posttransplantation sirolimus blood levels in renal transplant recipients. Ther Drug Monit. 1999;21:44-49.
10. Yatscoff RW, Faraci T, Bolingbroke P. Measurement of rapamycin in whole blood using high-performance liquid chromatography. Ther Drug Monit. 1992;14:138-141.
11. Svensson J-O, Brattström C, Säwe J. Determination of rapamycin in whole blood by HPLC. Ther Drug Monit. 1997;19:112-116.
12. Holt DW, Lee T, Johnston A. Measurement of sirolimus in whole blood using high-performance liquid chromatography with ultraviolet detection. Clin Ther. 2000;22(Suppl B):B38-B48.
13. Wakkers PJM, Hellendoorn HBA, op de Weegh GJ. Applications of statistics in clinical chemistry: A critical evaluation of regression lines. Clin Chim Acta. 1975; 64:173-184.
14. Cornbleet PJ, Gochman N. Incorrect least-squares regression coefficients in method comparison analysis. Clin Chem. 1979; 25:432-436.
15. Altman DG, Bland JM. Measurement in medicine: The analysis of method comparison studies. Statistician. 1983;32: 307-317.
16. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;i:307-310.
17. Groth CG, Bäckman L, Morales J-M, et al. Sirolimus (rapamycin)-based therapy in human renal transplantation. Transplantation. 1999;67:1036-1042.